Form 8-K - Current report:
SEC Accession No. 0001650664-25-000086
Filing Date
2025-06-02
Accepted
2025-06-02 17:28:58
Documents
14
Period of Report
2025-05-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K edit-20250529.htm   iXBRL 8-K 71493
2 EX-3.1 edit-charteramendmentautho.htm EX-3.1 6231
3 EX-10.1 amendedandrestated2015stoc.htm EX-10.1 116277
  Complete submission text file 0001650664-25-000086.txt   340003

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT edit-20250529.xsd EX-101.SCH 1803
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT edit-20250529_lab.xml EX-101.LAB 22532
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT edit-20250529_pre.xml EX-101.PRE 13057
16 EXTRACTED XBRL INSTANCE DOCUMENT edit-20250529_htm.xml XML 3091
Mailing Address 11 HURLEY ST. CAMBRIDGE MA 02141
Business Address 11 HURLEY ST. CAMBRIDGE MA 02141 617-401-9000
Editas Medicine, Inc. (Filer) CIK: 0001650664 (see all company filings)

EIN.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37687 | Film No.: 251016236
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)